World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
23534
World Ranking
19058
National Ranking
9500

Mary E.D. Flowers publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mary E.D. Flowers sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 198 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mary E.D. Flowers D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mary E.D. Flowers sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mary E.D. Flowers is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on medicine, with a substantial body of work in hematology, public health, environmental and occupational health, oncology, surgery, and genetics.

The scientist's work extensively covers hematopoietic stem cell transplantation, which appears as the most frequent topic in their publications. Other significant research topics include acute lymphoblastic leukemia, acute myeloid leukemia, childhood cancer survivors' quality of life, chronic myeloid leukemia treatments, polyomavirus and related diseases, and renal transplantation outcomes and treatments.

Mary E.D. Flowers has contributed to several recent papers with notable publication venues and years:

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report, 2021, Transplantation and Cellular Therapy
  • Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium, 2021, Blood Advances
  • Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML, 2022, Blood
  • Steroid-refractory chronic graft-versus-host disease: treatment options and patient management, 2021, Bone Marrow Transplantation
  • CMV viral load kinetics as surrogate endpoints after allogeneic transplantation, 2020, Journal of Clinical Investigation

The primary publication venues where Mary E.D. Flowers' work appears include:

  • Transplantation and Cellular Therapy
  • Blood Advances
  • Bone Marrow Transplantation
  • Journal of Bone Marrow Transplantation and Cellular Therapy
  • Blood

Frequent collaborative partners in their research efforts include Stephanie J. Lee, Paul A. Carpenter, Lynn Onstad, Adriana Seber, and Vaneuza Araújo Moreira Funke. These coauthors have contributed to numerous publications alongside Mary E.D. Flowers.

The scientist's expertise spans fields involving complex treatments such as stem cell transplantation and leukemia research, as well as broader concerns related to public health and occupational health. Their multidisciplinary approach covers clinical trials, patient management, and the study of outcomes following transplantation and cancer therapies.

Best Publications

  • HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

    Leo Luznik;Paul V. O'Donnell;Paul V. O'Donnell;Heather J. Symons;Allen R. Chen

  • Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

    Peter A. McSweeney;Peter A. McSweeney;Peter A. McSweeney;Dietger Niederwieser;Dietger Niederwieser;Dietger Niederwieser;Judith A. Shizuru;Judith A. Shizuru;Judith A. Shizuru;Brenda M. Sandmaier;Brenda M. Sandmaier;Brenda M. Sandmaier

  • Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

    William I. Bensinger;Paul J. Martin;Barry Storer;Reginald Clift

  • Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

    K M Sullivan;E Agura;C Anasetti;F Appelbaum

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.

    Kieren A. Marr;Kristy Seidel;Monica A. Slavin;Raleigh A. Bowden

  • Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

    Howard M. Shulman;David Kleiner;Stephanie J. Lee;Thomas Morton

  • Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.

    Jan Storek;Monja A. Dawson;Barry Storer;Terry Stevens-Ayers

  • Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

    Carolina Berger;Carolina Berger;Mary E. Flowers;Mary E. Flowers;Edus H. Warren;Edus H. Warren;Stanley R. Riddell;Stanley R. Riddell

  • Allogeneic Peripheral Blood Stem Cell Transplantation May Be Associated With a High Risk of Chronic Graft-Versus-Host Disease

    Jan Storek;Ted Gooley;Muriel Siadak;William I. Bensinger

  • Marrow Transplantation for Chronic Myeloid Leukemia: The Influence of Plasma Busulfan Levels on the Outcome of Transplantation

    J.T. Slattery;R.A. Clift;C.D. Buckner;J. Radich

  • Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning

    Frédéric Baron;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma

    Karen L. Syrjala;Shelby L. Langer;Janet R. Abrams;Barry Storer

  • Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report

    Daniel Couriel;Paul A. Carpenter;Corey Cutler;Javier Bolaños-Meade

  • A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

    Mary E D Flowers;Jane F. Apperley;Koen Van Besien;Ahmet Elmaagacli

  • Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

    Sibel Koc;Wendy Leisenring;Mary E. D. Flowers;Claudio Anasetti

  • Allogeneic hematopoietic stem cell transplantation for myelofibrosis

    H. Joachim Deeg;Theodore A. Gooley;Theodore A. Gooley;Mary E D Flowers;Mary E D Flowers;George E. Sale;George E. Sale

  • CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation

    J. Maciej Zaucha;Theodore Gooley;William I. Bensinger;Shelly Heimfeld

  • Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

    Afonso C. Vigorito;Paulo V. Campregher;Barry E. Storer;Paul A. Carpenter

  • PATHOPHYSIOLOGY AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE

    Mary E.D. Flowers;Mary E.D. Flowers;Emin Kansu;Emin Kansu;Keith M. Sullivan

Frequent Co-Authors

Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
H. Joachim Deeg
H. Joachim Deeg Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
Wendy Leisenring
Wendy Leisenring Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a wide range of healthcare-related fields. For those interested in advancing their nursing careers, the best online bsn to dnp programs are designed to help registered nurses achieve the highest level of clinical practice. This pathway is ideal for nurses aiming for leadership or specialist roles.

Pharmacists play a vital role in patient care and medication management. If this path interests you, consider an online pharmacy degree. These flexible programs are tailored for working professionals seeking enhanced credentials or career advancement.

Health information management is another growing sector. An online mhi equips students to manage vital patient data and health technology systems, ensuring quality and confidentiality in healthcare records.

For those seeking a fast entry into healthcare, medical billing and coding online programs offer foundational skills for organizing medical information and processing insurance claims. These roles are critically important for the smooth operation of healthcare facilities.

Best Scientists Citing Mary E.D. Flowers

Trending Scientists

Recently Published Articles